Xizang Weixinkang Pharmaceutical Co., Ltd. Class ASSE: 603676

Announcement on the Renewal of the Wholly-owned Subsidiary's Drug in the Catalogue of Drugs for Basic National Medical Insurance (2024)

· Issued by Xizang Weixinkang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Renewal of the Wholly-owned Subsidiary's Drug in the Catalogue of Drugs for Basic National Medical Insurance (2024)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis